NLS Pharmaceutics AG
Pharmaceutical ManufacturingView the employees at
NLS Pharmaceutics AG-
Eric Konofal Chief Scientific Officer chez NLS Pharmaceutics AG
-
Greater Paris Metropolitan Region
-
Rising Star
Eric Jean Desbois NLS Pharmaceutics AG Co-founder and Biotech Investor-
Paris, Île-de-France, France
-
Top 5%
Elena Thyen Pighin Finance expert | 10+ years' managing financial operations | passion for numbers and innovation | Love delivering financial integrity-
St Gallen, Switzerland
-
Rising Star
Overview
MISSION & VALUES To serve our patients we design affordable, safe and effective therapeutics to safeguard and empower the brain throughout all stages of life. We value partnership and Integrity, we are ethical and responsible and show respect and compassion for our patients. R&D STRATEGY The successful companies of tomorrow are those that go beyond delivering products to delivering real solutions and services. R&D is the cornerstone of our company and we promote ingenuity through an effective intellectual property policy. The advancements in science mean that more targeted, more (cost-)effective treatments are within reach and we are here to take on this challenge. Our innovative R&D is centered on patients’ needs and delivering affordable, safe and effective solutions. Not only will these enable us to improve access to quality healthcare and meet unmet needs, but they will also deliver the sustainable growth required to allow us to continue to invest in innovative research & development. FOCUS Partner in the field of psychiatry and neurology in attentionnal and cognitive enhancement and neurological therapies in particular. These disorders remain largely underdiagnosed and current therapies lack in safety and effectiveness: Attentional Disorders (ADHD, awakening disorders, deficit of alertness) Excessive Daytime Sleepiness (Narcolepsy, Hypersomnias) Pervasive Developmental Disorders (ASD) Cognitive Impairments (MCI, AD) Synucleopathies (PD, LB)
-